Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Guangfu Dang
Patients clinically diagnosed with Primary angle-closure glaucoma (PACG) and normal control patients from December 2020 to January 2022 were enrolled in this study.
Age
47–91
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
The depth of the anterior chamber is normal, and the whole corner of the chamber is open;
The cup-to-plate ratio is less than 0.5;
No family history of glaucoma.
You may not be if
Previous history of trauma or internal eye surgery in both eyes or one eye;
Used "pilocarpine", "atropine" and other drugs to change the size of the pupil and the shape of the chamber Angle within 1 week;
Combined with other eye diseases affecting the Angle and suspension ligament, such as uveitis, ciliary cyst, high myopia, retinal diseases, etc.;
